| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10744970 | Parkinsonism & Related Disorders | 2015 | 5 Pages |
Abstract
The FAB may not be a useful tool to differentiate PSP from FTDs, and shows no correlation with disease duration in these disorders. On the other hand, the essential information to differentiate PSP from PD and MSA-P is contained in the sum of only two FAB subscores. This should be taken into consideration in both clinical practice and the planning of clinical trials.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
M. Stamelou, J. Diehl-Schmid, A. Hapfelmeier, D. Kontaxopoulou, L. Stefanis, W.H. Oertel, K.P. Bhatia, S.G. Papageorgiou, G.U. Höglinger,